ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2022

Abstract Number: 0025

Wnt Pathway/Innate Immunity Equilibrium in OA Articular Cells

Eloi Franco-Trepat1, Ana Alonso Pérez1, María Guillán-Fresco2, Miriam López Fagúndez1, Andrés Pazos-Pérez3, Antia Crespo Golmar4, María Piñeiro-Ramil5, Ana Lois Iglesias6, Alberto Jorge-Mora1 and Rodolfo Gomez1, 1MSP Group - Institute IDIS - CHUS - SERGAS, Santiago de Compostela, Spain, 2MSP Group - Institute IDIS - CHUS - SERGAS, Catoira, Spain, 3MSP Group - Institute IDIS - CHUS - SERGAS, Pontevedra, Spain, 4MSP Group - Institute IDIS - CHUS - SERGAS, León, Spain, 5MSP Group - Institute IDIS - CHUAC - SERGA, A Coruña, Spain, 6MSP Group - Institute IDIS - CHUAC - SERGAS, A Coruña, Spain

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2022

Keywords: Cartilage Mechano biology, Inflammasome, innate immunity, Osteoarthritis, Therapy, alternative

Session Information

Date: Saturday, November 12, 2022

Title: Osteoarthritis and Joint Biology – Basic Science Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: The progressive degradation of osteoarthritis (OA) cartilage has been associated with articular innate immune responses (IIR) mediated by the Toll-like receptor 4 (TLR4). Additionally, overactivation of anabolic pathways like Wingless-Integrated (Wnt) has been linked to OA pathological process. However, certain anabolic signals can significantly reduce TLR4 activation. Accordingly, we aimed to determine whether the Wnt activation modulates TLR4 activity in human articular cells.

Methods: To do this, we evaluated the effect of diverse Wnt activators, (LiCl [0.1-20mM], Bio [1μM], and Wnt3a [100ng/ml]) and inhibitors (anti-β-catenin XAV-939 and PKF-118310) on TLR4 (LPS 100ng/ml) and IL1R (IL1β 0.1ng/ml) mediated IIRs. In primary human healthy & OA chondrocytes (hOC), osteoblasts (hOB), synoviocytes (hOS), mouse chondrocytes (ATDC5), human osteoblasts SaOs2, and human synoviocytes (SW982), gene expression of 25 inflammatory and catabolic genes were evaluated by RT-PCR in normal or TLR4 defective (siRNA) cells. Proteome and secretoma changes were determined by MALDI/TOFF and validated by ELISA. Cell responses were evaluated by MTT assay, Griess assay, and Green Malachite and CASP1 activity.

Results: Proteomic results revealed that LiCL activation of Wnt pathway inhibited innate immune responses mediated by receptors TLR4 & IL1R through the inhibition of the signaling pathways NLRP3/IL1, p38/MAPK, NFκB and promoted anabolic effects in articular cells isolated from OA patients. Specifically, LiCl [0.1-20mM] inhibited up to 99% of the gene and protein expression of NOS2, IL6, COX2, MMP9, MMP13, NLRP3, CASP1, IL1β and MAPK14 among other 25 biomarkers (Figure 1). Similar effects of LiCl were obtained with other WNT activators. TLR4 inhibition was validated using the specific TLR4-inhibitor CLI-095 as well as siRNA against TLR4 and NLRP3. Consistent with these data WNT inhibition further increased TLR4-mediated inflammatory responses (Figure 1). Interestingly, we identified that TLR4 and WNT pathway activation were mutually inhibited.

Conclusion: It is known that excessive activation of both TLR4 & WNT is deleterious in the OA context. Our results revealed that WNT activation blocked innate immune responses mediated by TLR4/IL1R in articular OA cells. Conversely, WNT inhibition promoted TLR4-mediated inflammation. Finally, we identified in chondrocytes that WNT and TLR4 were mutually inhibited (Figure 2). All in all, we found a new facet in both signaling pathways and shed some light on the complex OA environment which may prove critical to designing novel therapeutic tools to treat joint inflammatory pathologies.

Supporting image 2

Figure 1. Gene expression of AXIN2 (Wnt pathway) & LCN2 (TLR4/IL1 pathway)

Supporting image 3

Figure 2. Wnt & TLR4/IL1 pathway interrelationship


Disclosures: E. Franco-Trepat, None; A. Alonso Pérez, None; M. Guillán-Fresco, None; M. López Fagúndez, None; A. Pazos-Pérez, None; A. Crespo Golmar, None; M. Piñeiro-Ramil, None; A. Lois Iglesias, None; A. Jorge-Mora, None; R. Gomez, None.

To cite this abstract in AMA style:

Franco-Trepat E, Alonso Pérez A, Guillán-Fresco M, López Fagúndez M, Pazos-Pérez A, Crespo Golmar A, Piñeiro-Ramil M, Lois Iglesias A, Jorge-Mora A, Gomez R. Wnt Pathway/Innate Immunity Equilibrium in OA Articular Cells [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/wnt-pathway-innate-immunity-equilibrium-in-oa-articular-cells/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/wnt-pathway-innate-immunity-equilibrium-in-oa-articular-cells/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology